Clinical Study

Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients

Table 4

Association of HLA-B alleles with carbamazepine-induced SJS/TEN.

HLA-B allelesCarbamazepine-induced SJS/TEN ()Controls ()Thai population ()Carbamazepine-induced SJS/TEN cases versus tolerant controlsCarbamazepine-induced SJS/TEN cases versus Thai population
OR (95% CI) valueOR (95% CI) value

B07:052 (12.50%)12 (4.43%)24 (5.11%)3.08 (0.63–12.13)0.1652.65 (0.57–12.35)0.213
B13:011 (6.25%)37 (13.65%)54 (11.49%)0.40 (0.05–3.07)0.7090.48 (0.06–3.70)0.707
B15:011 (6.25%)10 (3.69%)5 (1.06%)1.63 (0.20–13.55)0.4945.81 (0.64–52.67)0.193
B15:0212 (75.00%)11 (4.06%)71 (15.11%)70.91 (19.67–255.65)4.46 × 10−1318.26 (5.79–57.61)6.9 × 10−8
B15:212 (12.50%)4 (1.48%)2 (0.43%)9.54 (1.61–56.57)0.01319.14 (2.51–146.09)0.004
B18:012 (12.50%)29 (10.70%)36 (7.66%)1.19 (0.26–5.51)0.8221.72 (0.38–7.88)0.483
B18:151 (6.25%)0 (0.00%)0 (0.00%)16.94 (1.01–183.39)0.11429.38 (1.76–490.97)0.069
B44:031 (6.25%)20 (7.38%)42 (8.94%)0.78 (0.10–6.22)1.0000.37 (0.05–2.89)0.484
B46:014 (25.00%)64 (23.62%)122 (25.96%)1.08 (0.34–3.46)0.8990.96 (0.30–3.03)0.947
B56:041 (6.25%)1 (0.37%)12 (2.55%)16.88 (1.01–282.35)0.1152.39 (0.29–19.48)0.374
B58:011 (6.25%)22 (8.12%)57 (12.13%)0.71 (0.09–5.59)1.0000.45 (0.06–3.48)0.707

SJS/TEN: Stevens-Johnson syndrome/toxic epidermal necrolysis; OR: odds ratio; 95% CI: confidence interval 95%. value less than 0.05.